GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,193,000 | +7036.0% | 325,900 | +3536.1% | 0.07% | +6700.0% |
| Q1 2022 | $311,000 | +11.9% | 8,963 | -5.7% | 0.00% | 0.0% |
| Q4 2021 | $278,000 | -30.8% | 9,500 | -39.8% | 0.00% | -50.0% |
| Q3 2021 | $402,000 | -90.3% | 15,771 | -86.7% | 0.00% | -87.5% |
| Q2 2021 | $4,139,000 | +86.6% | 118,223 | +117.2% | 0.02% | +60.0% |
| Q1 2021 | $2,218,000 | -80.5% | 54,441 | -79.2% | 0.01% | -80.0% |
| Q4 2020 | $11,347,000 | +1379.4% | 261,980 | +1783.7% | 0.05% | +900.0% |
| Q3 2020 | $767,000 | +16.7% | 13,908 | +33.7% | 0.01% | +25.0% |
| Q2 2020 | $657,000 | -48.8% | 10,400 | -58.6% | 0.00% | -60.0% |
| Q1 2020 | $1,283,000 | -59.1% | 25,100 | -36.5% | 0.01% | -54.5% |
| Q4 2019 | $3,140,000 | +1.1% | 39,500 | -38.3% | 0.02% | -18.5% |
| Q3 2019 | $3,105,000 | -18.4% | 64,000 | -11.5% | 0.03% | -18.2% |
| Q2 2019 | $3,803,000 | +52.5% | 72,300 | +53.5% | 0.03% | +73.7% |
| Q1 2019 | $2,493,000 | +508.0% | 47,100 | +371.0% | 0.02% | +533.3% |
| Q4 2018 | $410,000 | +81.4% | 10,000 | +74.7% | 0.00% | +200.0% |
| Q4 2017 | $226,000 | – | 5,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 356,069 | $16,094,000 | 8.69% |
| Perceptive Advisors | 4,828,910 | $218,266,000 | 5.72% |
| Grace Capital | 98,939 | $13,970,000 | 5.34% |
| GREAT POINT PARTNERS LLC | 770,400 | $34,822,000 | 4.83% |
| Camber Capital Management LP | 2,200,000 | $99,440,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 602,200 | $27,219,000 | 3.77% |
| Ghost Tree Capital, LLC | 242,000 | $10,938,000 | 3.22% |
| Casdin Capital, LLC | 480,000 | $21,696,000 | 3.03% |
| NEXTHERA CAPITAL LP | 404,092 | $18,265,000 | 2.83% |
| Asymmetry Capital Management, L.P. | 49,355 | $2,231,000 | 2.19% |